{"schema_version":"1","generated_at":"2026-10-28T02:31:34.391Z","data_as_of":null,"url":"https://www.findmykol.com/kol/alice-zervoudakis","json_url":"https://www.findmykol.com/kol/alice-zervoudakis/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"alice-zervoudakis","name":"Alice Zervoudakis","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Memorial Sloan Kettering Cancer Center","institution_url":"https://www.findmykol.com/institution/memorial-sloan-kettering-cancer-center","city":"West Harrison","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1306057963","orcid":"0009-0000-4818-7933","openalex":"A5056089551"},"summary":"Alice Zervoudakis is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 52 publications with 1,985 citations (h-index 16).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":52,"cited_by_count":1985,"h_index":16,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2023,"amount_usd":90.01,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1306057963"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1306057963","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":58.6,"classes_total":6,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":19.1,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":25},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":18.6,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":44}]},{"area":"Nervous system","share_pct":34.6,"classes_total":4,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":14.7,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":38},{"class":"Benzodiazepine","setting":"prescribed","share_pct":8.4,"drugs":[{"name":"Lorazepam","share_pct":100}],"max_beneficiaries":12}]},{"area":"Cardiovascular","share_pct":3.7,"classes_total":1,"classes":[{"class":"Antiarrhythmic","setting":"prescribed","share_pct":3.7,"drugs":[{"name":"Lidocaine-Prilocaine","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial","year":2026,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-026-04299-5","status":"verified"},{"title":"POLAR Trial | WES | cfDNA | mIF Correlative raw data and R script","year":2026,"journal":"Figshare","source_url":"https://doi.org/10.6084/m9.figshare.29874215","status":"verified"},{"title":"Nonoperative Management of Mismatch Repair–Deficient Tumors","year":2025,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2404512","status":"verified"},{"title":"Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma","year":2025,"journal":"JNCI Journal of the National Cancer Institute","source_url":"https://doi.org/10.1093/jnci/djaf139","status":"verified"},{"title":"Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial","year":2025,"journal":"Research Square","source_url":"https://doi.org/10.21203/rs.3.rs-7334701/v1","status":"verified"}],"source":"works"},"contact":{"address_1":"500 WESTCHESTER AVE","city":"West Harrison","state":"NY","zip":"106043200","phone":"917-367-7000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1306057963","source":"identity"},"similar":[{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"},{"name":"Mark Kris","slug":"mark-kris","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/mark-kris","json_url":"https://www.findmykol.com/kol/mark-kris/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-05-17","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}